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Abstract 
Background:  Heart failure (HF) is a progressive disorder which results in poor patient 
outcomes for those affected.  Although there are evidence-based medications to alter the 
progression and improve outcomes, provider adherence to these medications has been 
suboptimal.  Clinical decision support tools (CDS) within the electronic medical record are 
effective tools in medical management.  
Objective:  The primary objective was to evaluate the use of CDS to nurse practitioners 
(NPs) adherence of guideline-directed medical therapy in HF patients in the outpatient 
setting.  The secondary objective was to assess the NPs perception of facilitators and barriers 
that may affect the use of CDS.    
Methods:  A retrospective chart review was performed to extract HF measures and 
preventative care processes documented during an  18-month period by two NPs at two local 
primary care clinics in Southeast U.S.  Descriptive analysis of the chart data was performed 
to compare the results of the Centers for Medicare and Medicaid (CMS) National 
performance quality indicators.  Additional data was obtained from questionnaires that assess 
NPs perceptions and factors that affect the use of CDS.   
Results:  Collectively, the NPs performance fell below CMS results.  However, one NP 
exceeded CMS indicators in all areas except blood pressure control.  Although the NPs had 
some knowledge of CDS, CDS was not used with each patient contact.  The satisfaction of 
CDS among the NPs was mixed.  
Conclusion:  CDS use was not verified as a driving factor to the low-performance results as 
the use of CDS among the NPs was low.  Initiation or adjustment of HF therapy by the NPs 
could not be verified within this QIP.  Provider education of GDMT and CDS is key to 
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improving HF outcomes.  Further research using pre- and post-intervention analysis is 
warranted. 
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Nurse Practitioners Use of Clinical Decision Support Tools in Heart Failure Management 
 In March 2010, the Affordable Care Act (ACA) mandated that healthcare organizations 
replace paper-based records with electronic medical records (EMRs). The ACA provides 
incentives to providers who adopt electronic medical records (Kocher, Emanuel, and DeParle 
2010).  EMRs deliver many benefits to providers including access to patients’ medical history, 
current medical treatments, and clinical decision support tools (CDS).  CDS are evidence-based 
decision aids embedded within the EMR that provide guideline-directed reminders at the point of 
contact for timely clinical management of the patient (Vetter et al., 2015).  These tools can 
support and influence providers in the outpatient setting when providing care to patients with 
heart failure (HF) (Gold & McLaughlin, 2016).  Due to the chronicity of HF, nurse practitioners 
(NPs) are often charged with managing the care of this patient population in outpatient settings.  
Although practices for improvement are evolving, NPs are not using these aids to improve 
decision making in the management of patients with heart failure (Mitchell, Revere, & Ayadi, 
2014; Walsh et al., 2010).    
In this quality improvement project (QIP), the student investigator (SI) examines the 
background and significance of adequate HF management among NPs in the outpatient setting.  
A review of the literature is performed to assess CDS influence on NPs decisions when 
managing heart failure patients.  Finally, data from two NP-led primary care practices are 
analyzed using Donabedian’s Conceptual Framework to evaluate CDS use and the delivery of 
guideline-directed medical therapy (GDMT) in heart failure patients.  
Background and Significance 
Heart failure is a progressive multifactorial disorder that affects over 6 million adults.  
The incidence of HF doubles in men and triples in females across a ten-year span.  Individuals 
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over the age of 65 years of age have the greatest risk of developing HF.   African Americans 
have a greater incidence of HF than any other nationality (Benjamin et al., 2018; Yancy et al., 
2017).  Fifty percent of HF patients will die within five years of diagnosis (Benjamin et al., 
2018).  Current research trends show a declining incidence of HF but a rising prevalence of HF 
(Komanduri et al., 2017).  These changes may be due to an increase of awareness of HF signs 
and symptoms and improved diagnostic and treatment (Komanduri et al., 2017).  National 
hospital admission rates have doubled, and costs of care are expected to rise from $30 billion to 
$69 billion by the year 2030 (CDC, 2016; Komanduri et al., 2017).  In the state of Georgia, 
mortality rates are 5% greater than the national rates.  (Georgia Department of Public Health, 
2015). 
The American College of Cardiology (ACC), the American Heart Association (AHA) 
Task Force on Clinical Practice Guidelines and the Heart Failure Society of America (HFSA) 
have developed clear guidelines for the care of patients with HF (Yancy et al., 2017).  The 
guidelines include medications such as angiotensin-converting enzyme inhibitor (ACEi), 
angiotensin receptor blocker (ARB), an angiotensin receptor–neprilysin inhibitor (ARNI), and 
beta blockers (BB).  These medications have all proven to improve symptoms and extend life 
(Yancy et al., 2017).   
ACEI and ARBS are drugs that affect the renin-angiotensin-aldosterone system (RAAS) 
at different pathways within the system.  ACEi inhibits kininase and increase levels of 
bradykinin and is recommended for mild, moderate, or severe symptoms of HF. A major side 
effect of ACEi is angioedema and a cough.  ARBs do not inhibit kininase and are less associated 
with angioedema and cough (Yancy et al., 2017).  ACEi and ARBS have a 17% relative 
reduction rate of mortality and a 31% relative reduction rate hospitalization. ARNI is combined 
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with an ARB and a neprilysin inhibitor.  Neprilysin breaks down natriuretic peptides, bradykinin, 
adrenomedullin, and other vasoactive peptides.  ARNI has shown to reduce mortality and 
hospitalization by 20% for those with symptomatic HF who are naïve or previously tolerated an 
adequate dose of ACEi or ARB.  ACEi, ARBs, and ARNI should be used with caution in 
patients with low systemic blood pressures, renal insufficiency, or elevated serum potassium 
(Yancy et al., 2017).  BBs reduce the mortality rate by 35%.  BBs are better on improving 
ejection fraction, reducing ischemia, and the risk of sudden death.  BBs are recommended in all 
patients with mild to moderate heart failure.  A combination of a BB and ACEi, ARB, or ARNI 
is recommended particularly in those with HF with a reduced left ventricular ejection fraction.  
Recommendations for these GDMT are to start low and titrate to maximum effect (Yancy et al., 
2017).  Although these medications modify the progression and improve the quality of life for an 
individual with heart failure, clinicians do not utilize these therapies as recommended (Walsh et 
al., 2010). 
To improve the delivery of guideline-directed medical therapy (GDMT) and healthcare 
outcomes, the EMR may be beneficial (Gold & McLaughlin, 2016). The ACA provided financial 
incentives to providers who adopt and implement an EMR within their practice (Kocher et al., 
2010).  The goal was to increase access to healthcare information and improve healthcare 
outcomes (Kocher et al., 2010). Additional monetary incentives linked to health outcomes are 
provided by the Centers for Medicare and Medicaid (CMS) (Bardach et al., 2013).  EMRs are 
embedded with clinical decision support (CDS) tools that provide clinicians with specific 
evidence-based options to assist with the medical management of patients (Mitchell et al., 2014).   
CDS adherence improves outcomes (Mitchell et al., 2014; Niemi, Geary, Quinn, Larrabee, & 
Brown, 2009).  Also, providers can readily address CMS outcome measures with CDS.  The 
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Community Preventative Services Task Force (2013) recommend the use of CDS embedded with 
the EMR for the prevention of cardiovascular disease in the outpatient setting.  These 
recommendations were based on modest improvements in quality of care outcomes such as 
blood pressure control and smoking cessation.   As technology advances, CDS use has the 
potential for greater improvements in HF patients.  Without a deliberate effort to use this 
technology, the burden of heart failure will remain unchanged (Hopkins, 2015; Njie et al., 2015).  
Problem Statement 
NPs provide direct health care services to populations across the lifespan in various 
healthcare settings.  In the primary care setting, NPs are providing 90% of the services at a 
reduced cost and with the same liability costs as a primary care physician (Kraus & DuBois, 
2016).    The focus of the NP in this setting is the management and coordination of patients’ 
preventative and chronic health needs (Scordo et al., 2016).  Management of HF patients requires 
incorporating and integrating care among many providers (Kuo et al., 2018).  With adequate HF 
management, patients have decreased exacerbations, hospitalizations, and mortality rate 
(Mitchell et al., 2014; Connelly et al., 2012). Also, the evidence shows CDS improves 
preventative care processes in cardiovascular patients (Hopkins, 2015).  Despite the evidence, 
management of HF patients with GDMT is suboptimal (Walsh et al., 2010).   As an NP who uses 
clinical decision support tools for ordering, prescribing and educating patients in the inpatient 
cardiology setting, this QIP will examine the impact of CDS tools in improving the medical 
management in HF patients treated in the outpatient setting.   
Clinical Question 
Does the use of CDS tools impact a nurse practitioner’s adherence to guideline-directed 
medical therapy in adult patients with heart failure in the outpatient setting? 
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Review and Synthesis of the Literature 
Search Strategy 
  A literature review was performed using the following electronic databases: Cochrane 
Library, CINAHL, and PubMed Clinical Queries.  Several MeSH terms were used such as 
computerized decision support tools, clinical decision-making tools, electronic medical record, 
electronic health record, heart failure, adults, heart disease, guideline-directed therapy, provider 
adherence, acute heart failure, chronic heart failure, systolic heart failure, and diastolic heart 
failure.  These MeSH terms were used individually or in combination to find a variety of 
published evidence.  A total of 38 articles were found related to the use of CDS in various 
populations (i.e., diabetes, atrial fibrillation, and hypertension) within the outpatient and inpatient 
settings.  Articles were selected for review if they met the following inclusion criteria: CDS 
tools, adults only, range between 2008 and 2018, published in English, HF, and chronic disease 
processes.  
Search Results 
After careful review, a total of 11 articles were selected: three systematic reviews, three 
randomized controlled trials, and five observational studies.  In this review, three of the five 
studies published in the United States are observational.  Outcome targets in nine of eleven of the 
studies are related to providers, patients or both and health outcomes in two studies.  Health 
populations include heart failure and some form of cardiovascular disease (CVD). CDS is 
evaluated in nine out of ten the studies reviewed. 
Evidence Level and Quality 
The quality of the articles was evaluated using the Johns Hopkins Nursing Evidence-
based Practice Model (JHNEP). The model has three (I, II, II) levels for research evidence and 
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two (IV, V) levels for non-research evidence. The levels of research and type of trials are listed 
as follows: 
Level I: Random controlled trials (RCT) and systematic reviews (SR) of RCT 
Level II: Quasi-experimental studies and systematic review of mixed experimental 
studies.   
Level III: Non-experimental studies and systematic reviews of experimental and non-
experimental studies (Dang & Dearholt. 2017) 
Quality of evidence within this model is assessed at each level and appraised as (a) for 
high, (b) for good, and (c) for low based on the consistency of the results, level of control, and 
the strength of results and evidence (Dang & Dearholt. 2017).  The appraisal for the studies in 
this review is three-Ia, two-IIa, one-IIb, four-IIIa, and one-IIIb (Appendix A).   
Synthesis of the Evidence 
CDS on Outcomes.  In this QIP, the associations of CDS on provider and patient 
outcomes were neutral in some outcomes and modest in others (Arts, Abu-Hanna, Medlock, & 
van Weert, 2017; Peiris et al., 2015; Anchala et al., 2012; Gill et al., 2009; Pearson et al., 2009).  
Provider outcomes included measures such as ordering and prescribing patterns. Patient 
outcomes included patient lab values and processes for reducing cardiovascular disease (CVD) 
risk such as blood pressure control.   
Valadri et al., (2017) found acceptable rates of initial doses of BB at 86.4% and low rates 
of ACEi/ARBs at 60.3%.  The rates of optimal doses for BB and ACEi/ARBs were below 
acceptable rates.  The researchers noted that optimizing doses for these medications were not 
consistently noted in the charts (Valadri et al., 2017).  In another study, the use of ACEi, ARBs, 
and BBs was lowest among PCPs versus an HF team or a cardiologist in the outpatient setting 
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(Crissinger, Marchionda, & Dunlap, 2015).  There were modest improvements in the rates of 
target doses of ACEi and ARBs with no significant improvements in optimal doses of BBs in a 
comparison study of EMR use to paper charting in HF quality indicators (Walsh et al., 2010).  
Furthermore, researchers found there were low provider performance rates in four heart failure 
measures with CDS implementation versus post-implementation, and rates were lowest in the 
southern region of the United States (Mitchell et al., 2014).   
In an SR, there were insignificant improvements with preventative care related to blood 
pressure management in four studies with CDS use, however the one study with improvements 
HF measures noted improvements were at the cost of increased hospital readmissions (Anchala 
et al., 2012).   The results of an RCT had improvements in screenings for CVD risk factors with 
CDS use, but low rates of evidenced-based drugs in individuals at high risk of CVD (Peiris et al., 
2015).  A small significant effect of CDS use was noted on quality measures for lipid testing for 
patients at high-risk for CVD and in lipid screening (Gill et al., 2009).  Findings of increased 
financial savings with fewer laboratory, procedures, and prescription orders were noted when 
researchers evaluated the EMR effect on HF outcomes in the emergency room (Connelly et al., 
2012).   
Impact related to CDS.  The impact of CDS on hospitalizations, 30-day readmissions 
and mortality were mixed.  Among three studies that reported on hospitalizations and mortality, 
two showed a positive impact of CDS use and readmissions (Mitchell et al., 2014; Anchala et al., 
2012; Connelly et al., 2012).  There was one study with a positive association with CDS and a 
reduction of 30-day readmission (Connelly et al., 2012).   
CDS Adherence Factors.  In most of the studies, provider adherence to CDS and GDMT 
was low.  The barriers related to provider adherence included lack of time, too many system 
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alerts, EMR limitations (Arts et al., 2017).   Other barriers included provider awareness, 
knowledge, and experience with CDS.  Valadri et al. (2017) suggest inconsistent documentation 
practices among primary care providers may contribute to the perception of a lack of adherence 
to GDMT.  Facilitators to use of CDS and GDMT were educational and administrative support 
during the implementation of CDS but was only beneficial with provider acceptance (Pearson et 
al., 2009; Walsh et al., 2010).   Pearson et, al (2009) examined mostly RCTs in a systematic 
review that showed GDMT adherence was more successful with educational support (Pearson et, 
al 2009).  In an RCT, the researchers propose educational support for provider adherence to CDS 
and GDMT as post ad hoc improvements were noted in primary and secondary CVD 
management (Peiris et al., 2015). 
Gap Analysis 
Despite the claims that CDS improves healthcare outcomes, the results of the evidence 
are inconsistent.  The impact of CDS on these outcomes was not statistically significant in most 
articles reviewed (Arts, et al., 2017; Bryan & Boren, 2008; Gill, 2009; Pearson et al., 2009; 
Peiris et al., 2015; Anchala et al., 2012; Walsh et al., 2010).   Only a few studies reported on 
heart failure outcomes among NPs and the use of CDS.  The articles related to HF (N=5) focused 
mostly on physicians and inpatient care and two that examined the effect of CDS.   Sample bias, 
choice of outcome measures, and diverse EMR technology were provided as issues with designs 
of some studies (Arts, at al., 2017; Anchala et al., 2012; Bryan & Boren, 2008).   
Project Objectives 
The primary objective of this DNP project was to evaluate CDS impact on NPs adherence 
of GDMT in HF patients in the primary care setting.  Audits of charts were completed for heart 
failure patients seen during 01/01/2017-06/30/2018 by evaluating the frequency GDMT and 
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preventative care documented within the patient's chart.  The charts’ data extracted were 
documentation of an ACEi or ARB, ARNI, BB, smoking cessation counseling, and blood 
pressure control.  Secondary objectives were to assess the nurse practitioners perceptions of 
facilitators and barriers in the use of CDS.   Any hospitalizations or deaths were included if 
documented during the study period. 
Conceptual/Theoretical Framework 
A conceptual framework is an atlas that shapes and supports a research question and 
provides clarity by integrating conceptual processes (Moran et al., 2017).  Donabedian’s 
conceptual framework is a framework for a quality healthcare inquiry (Berwick & Fox, 2016).  
Avedis Donabedian’s framework utilizes a three-tier approach to evaluate quality in healthcare 
(Ribeiro-Bittencourt, Ferreira-Santana, Kassladou-Menezes, Cimador & Delvalle, 2016).   The 
framework consists of tenets created to evaluate management specifically, structure, process, and 
outcome (Ribeiro-Bittencourt et al., 2016).  These tenets or constructs were used to guide the 
DNP research question. 
According to Sund, Iwarsson, and Brandt (2015), the structure within the framework 
includes permanent or temporary organizational constructs, which may include cost and 
regulatory guidelines.  Process refers to the standards of care and evidence-based guidelines 
within healthcare practices including the ability to identify, diagnose and provide appropriate 
care (Ribeiro-Bittencourt et al., 2016). The outcome is the final construct and relates to the 
results of the research question as related to competency and clinical behavior (Ribeiro-
Bittencourt et al., 2016).   
 The constructs within the Donabedian’s framework are beneficial to the DNP project as it 
examines variables that affect a project’s structure and outcome (Moran et al., 2017).  Also, it 
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adds value to a project’s variables by showing meaningful relationships within the constructs of 
the framework.  McKay & Wieck (2014) eludes to the dynamic nature of the framework stating, 
“changes in structures and processes of care are required to optimize patient outcomes” (p. 249).   
 Donabedian’s conceptual framework when applied to the proposed DNP project, will 
guide the inquiry to assess outcome quality resulting from the research question.   The constructs 
as it relates to the project’s variables are as follows:   
Structure: Two primary care clinics using EMR integrated with CDS to deliver 
GDMT to HF patients 
Process:  Documentation of ACEi, ARB, ARNI, and a BB or contraindication of these 
medications, and documentation of blood pressure control <140/90 and smoking 
cessation screening and counseling   
Outcome: Chart audit results of process documentation measures and comparison to 
CMS 2016 performance results 
Donabedian’s conceptual framework will provide structure, definition, and clarity to 
investigate, predict, and evaluate the proposed project clinical question. 
Methodology 
  In this QIP, data from a retrospective chart review and questionnaires were evaluated 
using descriptive analysis.  The quantitative design allowed the SI to quantify the study variables 
(Bonnel & Smith, 2014).  Descriptive non-experimental methods were used to better understand 
the results of the question (Bonnel & Smith, 2014).    
Data collection using chart audits offered an inexpensive opportunity to understand past 
data. The process was easy and less time consuming than methods in experimental design 
(Barick et al., 2018).   The providers provided answers to the open-ended questionnaire that 
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asked about the nurse practitioner use and perceptions of clinical decision support tools in the 
outpatient setting.  Follow-up face-to-face visits were performed to obtain additional comments.   
Ethical considerations 
 Approval for the QIP was obtained from Georgia State University Institutional Review 
Board (IRB).  Informed consent was also granted for the participating NPs.  Letters of 
cooperation were obtained from two local primary care clinics.  
Population/Sample 
Sampling Method 
Convenience and purposive sampling methods were used for the selection of chart reviews 
and primary care NPs.  These non-probability sampling methods were chosen versus a 
probability method because the population is readily accessible, appropriate for the needs of the 
project, and financial costs were negligible (Jager, Putnick, & Bornstein, 2017). 
Sampling Criteria 
The sample size was derived from the monthly patient volume and nurse practitioner 
staffing of each clinic. The monthly patient load was approximately 300 in Clinic A with about 
12 active heart failure patients.  Clinic B patient load was approximately 400 with about 10 
active heart failure patients.  A sample size of 30 charts from Clinic A and 40 charts from Clinic 
B will be adequate for review.  The sample size for the NPs answering the questionnaire was 
two, one from each of the participating clinics.   
Participants and Inclusion/Exclusion Criteria 
The inclusion criteria for chart review included adults 18 years old or greater with a 
diagnosis of heart failure with or without symptoms seen between 01/01/2017-06/30/2018.  
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Patients with known obstructive pulmonary disease or asthma were excluded as exacerbation are 
sometimes difficult to ascertain, and BBs are controversial in this population (Lim et al., 2017).   
The inclusion criteria for NP data included board-certification as a nurse practitioner, at 
least three years practicing in the outpatient setting and manage heart failure patients.  Of the two 
participating NPs, one holds a master’s degree in nursing, and the other has a Doctor of Nursing 
Practice.  Both NPs have board certifications as family practice nurse practitioners and more than 
three years practicing as an NP in the outpatient setting, and both NPs manage heart failure 
patients.  
Setting 
The two participating clinics are located in the south Atlanta metropolitan Counties of 
Henry and Clayton.  According to the 2010 U.S. Census Bureau, Clayton County has a 
population of about  259,424 with about 58,797 over the age of 18 and Henry County has a 
population of 203,922 with about 59,657 over the age of 18.    
Clinic A is located in Forest Park, Georgia and serves the population of Clayton County 
and provide care for patients age six months and greater.  The clinic has five examination rooms. 
The nurse practitioner treats about 15 patients a day and manages patients with heart failure. 
Clinic B is located in McDonough, Georgia and serves the people of Henry County and provide 
care for patients age six months and greater.  The clinic has four exam rooms.  The nurse 
practitioner treats about 20 patients a day and manages patients with heart failure.   
Both clinics have four full-time staff members: an administrator, front office receptionist, 
medical assistant, and a nurse practitioner.  The clinics use the same cloud-based medical health 
records system.  The system has clinical decision supports embedded to help with medical 
management. 
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Data Collection 
Chart review 
The student investigator (SI) extracted chart data from the electronic medical record of 
both clinics.  The SI identified a total of 34 charts based on inclusion criteria: 11 charts from 
Clinic A and 23 charts from Clinic B.  Two charts were randomly selected from both clinic sites 
to verify data initially reviewed for errors to improve reliability.   
The SI transcribed chart data onto the data collection sheet. Chart data variables included 
demographic information: medical record number, date of birth, gender, and ethnicity.  
Additional healthcare data abstracted include International Classification of Diseases (ICD)10 
diagnosis codes for heart failure and heart failure symptoms, the number of comorbid conditions 
(0-2, 3-4, ≥5), documentation of an angiotensin-converting enzyme inhibitor (ACEi), angiotensin 
receptor blocker (ARB), or a beta-blocker (BB), blood pressure, smoking cessation counseling,  
hospitalization, and death rates (Appendix B).   
Questionnaire 
A paper-based questionnaire was created by the student investigator to examine the nurse 
practitioner use and perceptions of clinical decision support tools in the outpatient setting.  The 
questionnaire was adopted and modified using a tool from the Agency for Healthcare Research 
and Quality to meet the requirements of the study (2012).  The questions included a checklist of 
structured answers.  Questions 1-5 were related to the design of the EMR and CDS.  Questions 
6-9 examined the use and perceptions of CDS. Questions 6-8 allowed the provider to explain any 
answer chosen.  Question 10 included six demographics questions for comparative provider 
analysis.  Question 11 assessed the provider’s perceived knowledge level of CDS. Provider data 
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included age, gender, ethnicity, clinical experience, knowledge, and perceptions of the use of 
clinical decision support tools (Appendix C).   
Reliability and Validity   
Reliability of the questionnaire is unknown to date.  A lack of evidence about the use of 
the questionnaire among nurse practitioners warrants a reliability analysis in the future.   The SI 
maintained data validity by designing the collection tools, defining the variables, and collecting 
the data for the retrospective chart review and the provider interview.  A follow-up review of 
data was performed by the SI of two charts from the initial audit for transcription accuracy. 
Data Evaluation 
The CMS (2018) quality measures were used to compare data extracted from the chart.  
The CMS measures include the provision of an ACEi or ARB, BB, and risk reduction with 
smoking cessation counseling, and blood pressure control (<140/90). 
Data Management and Analysis 
An analysis was performed comparing CMS measures to the treatment and management 
practices of the participating nurse practitioners to identify areas for improvement.   Data were 
analyzed using IBM’s Statistical Package for the Social Sciences (SPSS) version 25.  Descriptive 
statistics were used to quantify data variables (Sebastiao & St. Peter, 2018).  Data analysis 
included frequency, means, range and standard deviation (SD) to provide clarity to the data.  
Means and standard deviations were used for continuous variables such as age and blood 
pressure and percentage for categorical variables such as gender and co-morbid conditions (0-2, 
3-4, ≥5).   
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Results 
Chart Audits 
Data from 34 charts were extracted for the analysis.  There were eleven charts from 
Clinic A and 23 from Clinic B. Of the 34 charts; there were 14 with 53 multiple encounters, 
seven from each clinic.  There were 20 charts with a single encounter, four from clinic A and 16 
from clinic B. 
Of the total charts reviewed, 44.1 % male and female 55.9 % male.   The age of patients 
ranged from 35 to 86 years with a mean age of 62.91 (13.11).  Most charts reviewed belonged to 
patients documented as Black 82.4 % (Table 1).  
Table 1  
Demographic Characteristics of the Chart Sample (N=34)  
 
 
 
 
 
 
 
 
 
 
 
 
 
Demographic  
Clinic A 
N           % 
Clinic B 
N           % 
Total 
N           % 
Age (years)  
    35-44 1 9.1 1 4.3 2 5.9 
    45-54 3 27.3 4 17.4 7 20.6 
    55-64 5 45.5 6 26.1 11 32.4 
    65-74 0 0 6 26.1 6 17.6 
    75-84 2 18.2 5 21.7 7 20.6 
    84-96 0 0 1 4.3 1 2.9 
Gender     
 Male 7 63.6 8 34.8 15 44.1 
 Female 4 36.4 15 65.2 19 55.9 
Ethnicity        
 Black 11 100 17 73.9 28 82.4 
 White 0 0 6 26.1 6 17.6 
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The clinical characteristics of the sample included heart failure ICD codes, the number of 
co-morbidities (0-2, 3-4, ≥5), and symptoms (dyspnea, fatigue, edema, orthopnea, pulmonary 
rales, JVD, and hepatomegaly).  ICD 10 code I50.9 was the most frequent code documented for 
heart failure, unspecified 52.9% (n = 18).  The code I50 was the second most code noted and is 
unbillable.   The chart review showed patients had at least one co-morbidity, 0-2 co-morbidities 
(29.4%), 3-4 co-morbidities (61.8 %) and, ≥5 co-morbidities (8.8%). Those that presented with 
symptoms were 35.3%.  (Table 2).   
Table 2  
Chart Sample Characteristics 
Clinical Characteristic 
Clinic #1 Clinic #2 Total 
n 
 
% n % n % 
ICD 10 Code       
   I50 6 54.5 0 0 6 17.6 
   I50.1 1 9.1 0 0 1 2.9 
   I50.3 4 36.4 1 4.3 5 14.7 
   I50.9 0 0 18 78.3 18 52.9 
   R06.00 0 0 3 13.0 3 8.8 
   R06.01 0 0 1 4.3 1 2.9 
Number of Co-Morbidities             
   0-2 3 27.3 7 30.4 10 29.4 
   3-4 7 63.6 14 60.9 21 61.8 
   ≥5 1 9.1 2 8.7 3 8.8 
Symptoms       
   Yes 2 18.2 10 43.5 12 35.5 
   No 9 81.8 13 56.5 22 64.7 
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Charts documented as smokers with smoking cessation counseling was 47.1%, 32.4% 
were non-smokers, and 20.6% did have documented evidence.  BP control was 41.2% for 
<140/90 and 58.8% for >140/90.  The mean systolic blood pressure was 149.32 (range 97-230, 
SD=29.238) and the mean diastolic blood pressure was 79.85 (range 55-116, SD = 13.87) (Table 
14).  The results for GDMT was 55.9% (ACEI 32.4%, ARB 17.6%, ARNI 5.9% 
contraindications (CIs) 17.6%).   Documentation was missing for 26.5% of the charts.  There 
were 79.4% charts with a documented BB, 17.6 % with CI to therapy and 2.9 % without 
documented therapy within the chart (See Table 3).  
Table 3 
Process Outcomes (N=34) 
Process 
Clinic #1 Clinic #2 Total 
n 
 
% n % n % 
Smoking Cessation Counseling  
    Smokers - - 16 69.6 16 47.1 
    Non-smokers 4 36.4 7 30.4 11 32.4 
    Not documented 7 63.6 - - 7 20.6 
Blood Pressure ≤140/90       
   Yes 4 36.4 10 43.5 14   41.2 
   No 7       63.6 13 56.5 20    58.8 
 RAAS Therapy        
   ACEI 3 27.3 8 34.8 11 32.4 
   ARB 2 18.2 4 17.4 6 17.6 
   ARNI - - 2 8.7 2 5.9 
   CI 1 9.1 5 21.7 6 17.6 
   Not documented 5 45.5 4 17.4 9 26.5 
Beta Blocker       
   BB 7 63.6 20 87.0 27 79.4 
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   CI 3 27.3 3 13.0 6 17.6 
   Not documented 1 9.1 - - 1 2.9 
The process data measures were evaluated using CMS quality measures.   CMS quality 
measures results were reported as an average of individual providers’ performances for each 
measure.  The providers participating in the CMS incentive program are included during the 
2016 reporting period.  NPs (N=134,464) were the largest group of providers participating in 
incentive programs.  However, reporting was low at 14.7% (Table 4).  The CMS results 
measures for comparison of this project were ACEi/ARB/ARNI/CI therapy 78.1 %, BB/CI 
therapy 83.1%, smoking cessation counseling 91.5 %, and blood pressure control 64.7% (Table 
5). 
Table 4 
CMS Quality Reporting Participating Provider Types 
 
Rank 
 
Specialty or Provider 
Type 
   
Eligible 
N 
Participated 
N 
% 
5 Family Practice 115,536 24,511 21.2% 
6 Nurse Practitioner 134,404 19,809 14.70% 
7 Physician Assistant 93,496 19,280 20.60% 
Table 5 
PQRS Average Performance Measures 
Measure 
Number 
Measure Description 
 2015-2016 
N 
Average 
2015 
Average 2016 
5 ACE/ARB LVSD 2,274 79.2% 78.1% 
8 BB LVSD 1,734 82.2% 83.1% 
226 
Tobacco Screening 
and Cessation  
80,717 90.3% 91.5% 
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236 
Controlling High 
Blood Pressure 
28,916 63.7% 64.7% 
The clinical data abstracted included hospitalization and deaths.  There were 17.6% 
hospitalizations documented 17.4 (n=6) and 2.9% (n=1) documented as deceased for clinical 
data (Table 6). This data was included as mortality and hospitalization are the clinical outcomes 
that provide evidence of improvements.  This information reveals changes in the HF burden.  
Hospitalizations and deaths were topics beyond the scope of the QIP but important data to 
highlight.   
Based on the literature, HF patients discharged from the hospital has higher mortality and 30-day 
readmission risks if not managed with GDMT as recommended. 
Table 6 
Clinical Outcomes (N=34) 
 
Clinical 
Clinic #1 
n       % 
Clinic #2 
n     % 
Total 
n      % 
Hospitalization     
   Yes 2 18.2 4 17.4 6 17.6 
   No 9 81.8 19 82.6 28 82.4 
Deaths       
   Yes - - 1 4.3 1 2.9 
   No 11 100.0 22 95.7 33 97.1 
 
Donabedian Framework and Measures Comparison 
A comparison of CMS measures to the provider's process results was performed using 
Donabedian framework.  According to the tenet of structure, chart encounters were evaluated 
and compared to CMS measures individually and with both clinics combined.  The charts audit 
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sample (N=34) were broken down based on those with multiple (n=14) and single (n=20) 
encounters.   
Clinic A had a larger number of multiple encounters while Clinic B had a larger number 
of single encounters.  The process measures were compared between clinics which revealed 
Clinic B performed better in all measures except BP control which were 50% and 37.5% 
respectively. The combined total of both clinic outcomes was compared to CMS outcome 
measures.   The clinics fell below all measures when compared to the CMS measures (Table 7).  
Table 7 
Comparison of Clinic and CMS Process Measure using Donabedian’s Framework 
 
Structure 
CDS 
Single Encounters   Outcome Multiple Encounters Outcome CMS 
Clinic 
Chart  
A 
n=4 
B 
n=16 
 ND N=20 
A  
n=30 
B 
n=23 
ND 
 
N=53 
 
Process Measure          
ACEI/ARB/ 
ARNI/CI 
50 81.3 25 75 56.7 78.3 34 66 78.1 
BB/CI 75 81.3 20 80 60.0 100.0 22.6 77.4 83.1 
BP Control 
<140/90 
50 37.5 - 40 43.3 39.1 - 41.5 64.7 
Smoking Cessation  25 100 15 85 40 100 34.6 65.4 91.5 
Note: ND not documented 
Provider Questionnaire 
 Demographics of the providers were one male and one female within the age range of 45-
54, both self-identified as Black.  Both have advanced practice degrees: the male has a Doctor of 
Nursing Practice, and the female has a master’s in the science of nursing (Table 8).  
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The following questions allowed the SI to examine the use and perceptions of clinical 
decision support tools in the outpatient setting (Appendix C). 
1.  Based on each provider’s experience, the providers agreed that each clinic’s EMR 
could allow the user to complete all the tasks provided listed on the questionnaire.    
2.  Both providers selected yes that CDS was embedded in the EMR at each practice. 
3.  Both providers responded with a pop-up or drop-down box versus an audible alert. 
4.  The providers responded that each system allowed a bypass of the CDS presentation 
without a required response. 
5.  The providers selected CDS tasks and ease of use:  Clinic’s A provider selected 
decisions with lab orders with a rating of 8, and prevention of adverse event, support with 
decisions for preventative care, patient education, and patient counseling and rated each a 
10.  Provider from Clinic B selected and rated all the tasks ten including support with 
procedures, medications, referrals, and scheduling follow-up. 
6.  Provider from Clinic A, selected four facilitators to CDS use:  quality in healthcare 
commenting “due to CDS reminders”, access to up to date knowledge commenting 
“gives information on guidelines and up to date”, patient satisfaction with meeting their 
healthcare needs comments CDS “helps you to know what test to provide so patient is 
satisfied with care”, and support for comprehensive patient care with comments “if there 
are things that are missed, the CDT helps us to know what is missing”.  The provider 
from Clinic B selected all options listed for facilitators to CDS to use and did not provide 
any comments.    
7.   The provider at Clinic’s A commented that CDS use “does not interfere…use 
enhance judgment”.  Clinic’s A provider selected the use of CDS prolonged 
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documentation of patient care and commented:  “yes, but necessary documentation.”  The 
provider from Clinic’s B did not choose any of the pre-populated barriers writing 
“nothing applies.”  
8.  The provider from Clinic A selected use of CDS was sometimes commenting 
“sometimes use the tools if I glance at the notifications for the patient.  The provider from 
Clinic B selected most times without any explanation. 
9.  Clinic’s A provider, rated CDS satisfaction as a 2 and Clinic’s B provider satisfaction 
of CDS was 8. 
10.  Providers’ demographics information is noted above for each provider (Table 8).   
11.  Clinic’s A provider selected knowledge level of CDS was an average user whereas 
Clinic’s B provider chose an advanced user.  
Table 8 
Provider Demographics 
 
 
 
 
  
 
 
Discussion 
Although the results of the quality improvement project suggest that the practitioners are 
not in-line with CMS quality measures, the results should be examined with some amount of 
Demographics Provider 1 Provider 2 
Gender Male Female 
Age 45-54 45-54 
Race Black Black 
Hispanic/Latino No No 
Educational Level DNP MSN 
Knowledge Level of CDS Average User Advanced User 
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caution as this project did not control for variability in the data.   The documentation frequency 
for the NPs fell below CMS measures.  CMS data showed that ACEi/ARBs therapy was 78.1 %, 
BB therapy 83.1%, smoking cessation counseling 91.5 %, and blood pressure control 64.7%.     
Among the participating NPs, frequency results were ACEi/ARBs 55.9%, BB therapy 79.4%, 
smoking cessation counseling 47.1 %, and blood pressure control 41.2%. The GDMT 
documented within the charts was often not started or titrated by the NP.   There was missing 
documentation for ACEi/ARBS in 26.5% of the charts.   These findings are consistent with 
previous evidence as provider adherence is low, optimization of therapies difficult to determine, 
and incomplete documentation is problematic when evaluating the results. This practice of 
incomplete documentation is a concern as ACEi/ARBs have been shown to decrease 
hospitalizations which is a strong indicator to increase mortality (Valadri et al., 2017).   
The rate of documentation of smoking cessation and high blood pressure among the NPs 
in the QIP was 47.1% and 41.2% respectively.  As in previous evidence, results of preventative 
measures are insignificant and low, particularly in blood pressure management.  High blood 
pressure is also a major risk factor for cardiovascular disease.  Over 480,000 Americans die from 
the use of tobacco, and over 78,000 dies from high blood pressure (Benjamin et al., 2018).  
According to the American Heart Association, tobacco use increases the risk of cardiovascular 
disease and is a leading preventable risk factor of mortality (Benjamin et al., 2018). 
The information obtained from the questionnaires suggests that documentation is a 
problem among NPs as completion of the questionnaire became a lengthy process.  
Documentation was often completed at the end of the day for one provider.  One provider uses 
templates to cut-down on charting time.  Based on the results of the CMS quality report, nurse 
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practitioners are in large numbers managing patients with chronic illness, however of the 134 
thousand nurses able to transmit quality measures, only 14.7% NPs participated.  
Limitations 
The retrospective design of the QIP is a limitation.  The convenience sampling of the 
charts may not be representative of the general population (Vassar & Holzmann, 2013).  
However, this method was suitable for the QIP as the NPs practices were small and did not 
produce the number of charts expected for review.   Additionally, secondary data from chart 
review, possible loss of information, and inaccuracy in provider transcription are risks and 
threats to validity (Patawala, 2017).     
Another limitation was only two NP practices participated in the QIP which increased the 
risk of generalizability issues (Vassar & Holzmann, 2013).  Nevertheless, the results of this QIP 
highlighted problems in providers documentation which provides information for provider 
education and further research.   The number of charts sampled was smaller than anticipated.  
The data from the final chart sample provided the SI with preliminary results for implications for 
future inquiry. 
Risk of bias was a limitation related to the exclusion of left ventricular ejection function, 
and the classification of heart failure as both are important values to consider when initiating 
GDMT in HF (Yancy et al., 2017).  
Also, unverifiable missing and incomplete data were limitations (Worster, 2004).  This 
missing data may have skewed the results and difficult to compare to CMS National measures.  
The SI selected to keep the charts because deleting the charts would have decreased the sample 
and created an increased bias (Worster & Haines, 2004).   The SI used missing data as a variable 
for post hoc improvement.   
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The providers’ answers to the questionnaire were mostly limited to a check mark and 
minimal comments which would have given the SI greater information to provide a robust 
evaluation.   Although both practices have EMRs embedded with CDS, both NPs states that CDS 
was not used with each patient contact.  The CDS were enabled in both EMRs. However, it was 
difficult to access use with HF management retroactively.  Documentation of process measures 
was also difficult to discern at what point of patient contact occurred.   Given this, it is difficult 
to establish any impact CDS could have had with NPs management of HF patients. 
Summary and Applicability to Practice 
The burden of heart failure is well-known in the literature.  It affects over 6 million 
Americans, the cause of over a million hospitalizations annually, and is associated with increased 
mortality.   The use of GDMT has shown to improve the quality of life of those affected and 
decrease hospitalization and mortality.   Nurse practitioners, as first-line providers, must be able 
to manage these patients with GDMT effectively.  
Advance Practice Nurse Implications.  NPs are competent, well-qualified providers to provide 
care to individuals with multiple healthcare needs (Bardach et al., 2013).  Furthermore, the 
primary care provider plays an essential role in outpatient heart failure management.  The results 
of a large trial by the Veteran Administration (VA) supports NPs in providing quality services by 
showing that NP-led clinics in rural areas had a reduction in hospital admissions and mortality in 
heart failure patients while decreasing costs and filling the gap in healthcare services (Lowery et 
al., 2012).  Optimization of GDMT requires frequent close monitoring of vital signs, volume 
status, and laboratory findings.  Frequent cardiology visits are usually less practical than visits to 
the primary care office.  NPs in primary care must be empowered to initiate, titrate, and manage 
GDMT to improve healthcare outcomes (Valadri et al., 2017). 
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Failure to meeting quality indicators and CDS recommendations can have various 
implications.  Missing or incomplete documentation can lead to penalties from CMS and skew 
results of evidence-based studies (Austria, 2015).   Non-compliance of quality indicators may 
support allegations of negligence.  Inaccurate claim codes can result in monetary loss and lead to 
charges of fraud (Austria, 2015).   
Patient Implications.  Patient safety is compromised due to incomplete or poor clinical 
practices.  Failure to optimize GDMT can worsen HF-related symptoms and outcomes leading to 
patient injury, death, and malpractice claims (Austria, 2015).  Furthermore, inadequate clinical 
practices can lead to decreased patient satisfaction and confidence. 
Policy Implications. Current Regulatory and scope of practice policies limit o clinical practices 
delivered by NPs.  Clinical practice failures may support increased limitations and more stringent 
policies for NPs seeking independent practice (Austria, 2015).  Likewise, current reimbursement 
models reimburse NPs at lower rates than physicians for the same clinical services and claims 
codes.  The results of inaccurate coding may lead to no reimbursement or fraud and incomplete 
documentation to imposed penalties for low performance (Austria, 2015). CMS will assess 
penalty fees to providers who care for Medicare and Medicaid patients and do not achieve 
quality measures goals (CMS, 2018). 
Conclusion 
The evidence provides data about provider differences, educational support and clinical 
management incentives that affect adherence to CDS, GDMT and HF outcomes.  NPs must 
increase their knowledge of CDS by utilizing educational and technical support to become more 
confident in managing complex patients and compliance of GDMT (Walsh et al. 2010).   
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CDS are support tools to influence the providers to deliver evidence-based therapies. 
However, a critical gap between guidelines and practice is provider adherence.  More evidence is 
needed targeting NPs as most articles reviewed in this QIP targeted physicians or physician 
practices.   Stronger evidence supporting NPs use of CDS when managing HF in the outpatient 
setting is vital to help decrease morbidity and mortality in this population because the HF burden 
is forecast to increase (Komanduri et al., 2017).    
The NPs in this QIP would benefit in further education on CDS, GDMT, CMS quality 
measures for improved management and documentation of HF patients.  Innovative designs for 
educational and technical support are important for provider engagement and acceptance of CDS 
when treating heart failure patient (Walsh et al. 2010).   CDS are valuable tools for providers that 
can have a positive influence on disease management health outcomes in the outpatient setting 
(Arts, at al., 2017; Peiris et al., 2015; Anchala et al., 2012; Walsh et al., 2010; Gill, 2009).  
Dissemination 
The plan for dissemination of this QIP includes a formal presentation to defend to the 
DNP staff, colleagues, and team members.  Also, the SI will deliver a formal presentation to the 
two clinics that participated in the project.  An abstract was accepted to be included the Annual 
Lewis College Graduate Research Conference.  Finally, a post hoc case study to educate NPs in 
the community regarding using CDS in heart failure management and outcome improvements 
and submit a case study for publication. 
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Appendix A:  Review of Literature Matrix 
Review of Literature Matrix 
 
 
 
 
Author Design Country Sample Measurement Results Target Strength 
Arts et al., 
2017 
RCT Netherlands N=731 
PCP clinic 
Provider 
adherence with 
CDS; document 
reason for non-
adherence 
Low use of CDS; noted reason, 
non-capture 
-Barriers: lack of time, too may 
alerts, limitation in system 
function 
Provider 
Afib 
 
Ia 
Valadri et al., 
2017  
OBS U.S. N=155 Provider 
adherence 
GDMT in HF 
Low Optimization of GDMT 
-PCP reluctant d/t possible 
cardio-renal imbalances 
Provider 
HF 
IIIa 
Crissinger et 
al, 2015 
OBS U.S. N-641 
307 HF, 
258 CV, 
and 76 
PCP. 
Differences in 
GDMT therapy 
among provider 
types: PCP, CV, 
HF team 
HF teams adhered most often 
target and optimal therapies  
-PCP low adherence 
 
Patient 
HF 
 
IIIb 
Peiris, et al., 
2015 
RCT Australia N=60  
outpatient 
clinics: 30 
communit
y/ 30 GP 
CDS QI effect 
on CVD risk 
management and 
prescription rates 
Positive effect on CVD 
preventative management; no 
effect on prescription rates 
Provider 
CVD 
 
Ia 
Mitchell, et al., 
2014 
OBS U.S. N=2335 
hospitals 
CDS effect on 
30-day 
admission and 
CMS process HF 
measures 
Positive correlation with CDS on 
30-day readmission rates; no 
correlation with CMS HF 
measures 
Clinical 
Provider 
HF 
 
 
IIIa 
Connelly, et 
al., 2012  
OBS   US N=5166  
3 ED  
EMR effect on 
hospitalization, 
LOS, inpatient 
mortality  
2/3 lower mortality, 1/3 lower 
hospitalization, 1/3 prolonged 
ED stay; however, decrease 
procedure/labs orders  
Clinical 
Provider 
HF 
 
 
IIIa 
 
Raghupathy et 
al., 2012 
SR-MA Multiple N=10 CDS effect on 
prevention of 
CVD, HF, 
TIA/CVA and 
CAD 
Variable results on prevention: 
no effect on HF; increased on 
TIA/CVA w/o impact; HF 
improved processes at cost of 
increased readmission rates; 
30% reduction AMI; however, 
no differences between groups 
on mortality or readmission 
Patient 
CVD 
IIb 
Walsh et al., 
2010 
OBS U. S N=167 
Outpt 
Target: 
HF PT 
EHR vs paper: 
on CMS quality 
measures 
CDS with moderate effect 
measures: ACEi/ARB/BB 
Provider 
HF 
IIIa 
Pearson et al., 
2009 
SR Multiple N=56 
50-RCT 
6-Quasi-
exp 
Impact CDS on 
prescribing 
practices in inpt 
vs outpt setting 
16 related to CVD- 4 showed 
positive impact on majority of 
outcomes 
Provider 
CVD 
IIa 
Gill et al., 
2009 
RCT U.S. N=25 
12 I 
13 C 
CDS effect on 
lipid testing, 
goals and # of 
prescription 
Lipid testing increased 
LDL-C goal increased 
Increased # of prescriptions.  
No differences among groups  
Provider 
CVD 
Ia 
 
Bryan & 
Boren, 2008 
SR US N=17:  
12RCT 
5-NRCT 
CDS effect 
healthcare 
outcomes 
13-positive or variable outcome; 
4- no significant outcome 
Provider 
Patient 
CVD 
Depression 
IIa 
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Appendix B:  Chart Audit Tools 
Table B1:  Abstraction Tool 
Data Abstraction Tool 
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Table B2:  Abstraction Tool Code Sheet 
 
 
 
CODES DESCRIPTION 
DYSPNEA 
J80 Acute respiratory distress syndrome 
R06.00 Dyspnea, unspecified  
R06.01 Orthopnea  
R06.02 Shortness of breath  
R06.09 Other forms of dyspnea  
R06.89 Other abnormalities of breathing  
R06.9  Unspecified abnormalities of breathing 
FATIGUE 
G93.3  Post viral fatigue syndrome 
R53.0  Neoplastic (malignant) related fatigue 
R53.1  Weakness 
R53.81  Other malaise 
R53.83  Other fatigue 
EDEMA 
R60.0  Localized edema 
R60.1  Generalized edema 
R60.9  Edema, unspecified 
HEART FAILURE 
I50  Heart failure 
I50.9  Heart failure, unspecified; Biventricular (heart) failure NOS; Cardiac, heart or 
myocardial failure NOS; Congestive heart disease; Congestive heart failure; Right 
ventricular failure (secondary to left heart failure) 
I50.1  Left ventricular failure; Cardiac asthma; Edema of lung with heart disease NOS; 
Edema of lung with heart failure; Left heart failure; Pulmonary edema with heart 
disease NOS 
I50.20  Unspecified systolic (congestive) heart failure 
I50.21  Acute systolic (congestive) heart failure 
I50.22  Chronic systolic (congestive)  heart failure 
I50.23  Acute on chronic systolic (congestive) heart failure 
I50.30  Unspecified diastolic (congestive) heart failure 
I50.31  Acute diastolic (congestive) heart failure 
I50.32  Chronic diastolic (congestive) heart failure 
I50.33  Acute on chronic diastolic (congestive) heart failure 
I50.40  Unspecified combined systolic congestive) and diastolic (congestive) heart failure 
I50.41  Acute combined systolic (congestive) and diastolic (congestive) heart failure 
I50.42  Chronic combined systolic (congestive) and diastolic (congestive) heart failure 
I50.43 Acute on chronic combined systolic (congestive) and diastolic(congestive) heart 
failure 
I50.1 Left ventricular failure; Heart failure, unspecified; Biventricular (heart) failure NOS 
Cardiac, heart or myocardial failure NOS; Congestive heart disease; Congestive 
heart failure; Right ventricular failure (secondary to left heart failure 
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Appendix C:  Provider Questionnaire 
Clinical Decision Support Tools Survey  
Instructions 
When completing the questionnaire, you may leave blank any questions that you do not want to answer. We will 
keep your responses strictly confidential. This questionnaire has been designed to gather information about your 
perceptions on the use of clinical decision support tools among nurse practitioners in the outpatient setting.  
 Based on your experience, which tasks are you able to complete within the medical record?  
 
Choose all that apply  
Obtain and review patient information and data  
Document care for my patients  
View lab tests for my patients  
Prevent adverse events (e.g., drug-drug interaction, drug-allergy interaction)  
Track preventive care for my patients  
Manage chronic disease conditions for my patients   
Manage orders  
Manage referrals  
Provide patient educational materials  
Does your electronic medical record include clinical decision support tools?  
□ Yes 
□ No 
If so, in what format does the clinical decision support tools presented within the electronic medical record? 
□ Pop-up or drop-down box 
□ Audible alert 
Based on the format of the software for the clinical decision support tool, is there a requirement to respond or are you 
allowed to bypass the presentation? 
□ Required response 
□ Bypass 
Based on your knowledge of clinical decision support tools, which tasks do you use clinical support tools when 
managing patients? Rate the ease of completing each task on 0-10 scale 
 
Choose all that apply √ 
Decisions with lab orders  
Decisions procedure orders  
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Decisions with medication order  
Prevent adverse events (e.g., drug-drug interaction, drug-allergy interaction)  
Decisions with preventive care for my patients  
Decisions with referral  
Decisions with patient education, such medication  
Decisions with patient counseling  
Decisions with follow-up timing  
 
Based on your experience, identify and discuss factors that facilitate the use of clinical decision support tools within 
your practice? 
 
Choose all that apply √ Explain 
Costs of providing care    
Quality of health care   
Stress-level   
Provider and patient 
communication 
  
Access to up- to-date knowledge   
Patients' satisfaction with meeting 
their healthcare needs 
  
Your ability to manage more 
complex problems 
  
Providing comprehensive of 
patient care 
  
Efficiency of clinical practice   
Avoiding errors (such overlooking 
a drug) 
  
 
Based on your experience, identify and discuss any barriers that prevent the use of clinical decision support tools? 
 
Choose all that apply √ Explain 
Use interferes with patient 
interaction.  
  
Use has increased my workload.   
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Use does not enhance my 
judgment when managing a 
patient. 
  
Use prolongs documentation of 
patient care. 
  
Other   
 
Based on your experience, please indicate how often you use clinical decision support tools in 
your practice as a nurse practitioner? Explain 
 
√ 
Every time   
Most times   
Sometimes   
Not at all   
N/A   
 
Rate your satisfaction with clinical decision support tools on a scale from 0-10  
 
Tell me about yourself 
 
Gender Male  Female     
Age 
 
34 or less 35-44 45-54 55+   
Hispanic/Latino  Yes  No     
Race 
 
American 
Indian 
Asian Native 
Hawaiian or 
Pacific 
Islander 
Black 
African 
American 
White Other: 
(specify) 
________ 
Highest 
Education Level 
 
High School or 
GED 
2-year 
college 
degree 
(Associate) 
4-year 
college 
degree (BA, 
BS, BSN, 
etc.) 
Master’s 
degree 
(MA, MS) 
Doctoral 
degree 
(Ph.D., 
DNP, 
etc.) 
Profession
al degree 
(MD, 
PharmD) 
 
Choose the best description of your knowledge of clinical decision support tools   √ 
Novice (newly acquired knowledge)   
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Average user (knowledge of clinical decision support tools to manage patient and complete 
documentation) 
 
Advanced user (Knowledge to adjust clinical decision support tools based on your 
preferences) 
 
Expert user (Knowledge to set up and develop clinical decision support tools within the 
electronic medical record)  
 
Thank you for completing this questionnaire.  This information will help us better understand the use and perceptions 
of clinical decision support tools among nurse practitioner in the outpatient setting. 
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Appendix D:  Timeline 
Timeline 
Task Apr 
2018 
May Jun Jul Aug Sep Oct Nov Dec Jan  
2019 
Feb Mar Apr 
Proposal 
Approval  
x             
Proposal 
Presentation 
x             
IRB apply     x         
IRB approval     x         
Consent to 
Providers 
     x        
Interview with 
providers 
     x        
Chart review      x x       
Evaluation       x       
Analysis of 
outcomes 
       x x     
Results to team         x x    
Pre-Defense Paper          x    
Dissemination 
Plan 
          x   
Final paper to 
Team 
          x   
Abstract 
Submission 
          x   
Defense            x  
DNP Project 
Manuscript 
           x  
DNP Final Post 
Defense 
            x 
Complete IRB 
Closeout 
            x 
 
